Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "meet the Experts" 2015 Workshop Summary

Ramesh Akkina, Atef Allam, Alejandro B. Balazs, Joel N. Blankson, John C. Burnett, Sofia Casares, J. Victor Garcia, Kim J. Hasenkrug, Fatah Kashanchi, Scott G. Kitchen, Florian Klein, Priti Kumar, Andrew D. Luster, Larisa Y. Poluektova, Mangala Rao, Brigitte E. Sanders-Beer, Leonard D. Shultz, Jerome A. Zack

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The number of humanized mouse models for the human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) and other infectious diseases has expanded rapidly over the past 8 years. Highly immunodeficient mouse strains, such as NOD/SCID/gamma chainnull (NSG, NOG), support better human hematopoietic cell engraftment. Another improvement is the derivation of highly immunodeficient mice, transgenic with human leukocyte antigens (HLAs) and cytokines that supported development of HLA-restricted human T cells and heightened human myeloid cell engraftment. Humanized mice are also used to study the HIV reservoir using new imaging techniques. Despite these advances, there are still limitations in HIV immune responses and deficits in lymphoid structures in these models in addition to xenogeneic graft-versus-host responses. To understand and disseminate the improvements and limitations of humanized mouse models to the scientific community, the NIH sponsored and convened a meeting on April 15, 2015 to discuss the state of knowledge concerning these questions and best practices for selecting a humanized mouse model for a particular scientific investigation. This report summarizes the findings of the NIH meeting.

Original languageEnglish (US)
Pages (from-to)109-119
Number of pages11
JournalAIDS Research and Human Retroviruses
Volume32
Issue number2
DOIs
StatePublished - Feb 2016

Fingerprint

National Institute of Allergy and Infectious Diseases (U.S.)
HIV
Education
Research
HLA Antigens
Myeloid Cells
Practice Guidelines
Transgenic Mice
Communicable Diseases
Acquired Immunodeficiency Syndrome
Cytokines
T-Lymphocytes
Transplants

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Infectious Diseases

Cite this

Improvements and Limitations of Humanized Mouse Models for HIV Research : NIH/NIAID "meet the Experts" 2015 Workshop Summary. / Akkina, Ramesh; Allam, Atef; Balazs, Alejandro B.; Blankson, Joel N.; Burnett, John C.; Casares, Sofia; Garcia, J. Victor; Hasenkrug, Kim J.; Kashanchi, Fatah; Kitchen, Scott G.; Klein, Florian; Kumar, Priti; Luster, Andrew D.; Poluektova, Larisa Y.; Rao, Mangala; Sanders-Beer, Brigitte E.; Shultz, Leonard D.; Zack, Jerome A.

In: AIDS Research and Human Retroviruses, Vol. 32, No. 2, 02.2016, p. 109-119.

Research output: Contribution to journalArticle

Akkina, R, Allam, A, Balazs, AB, Blankson, JN, Burnett, JC, Casares, S, Garcia, JV, Hasenkrug, KJ, Kashanchi, F, Kitchen, SG, Klein, F, Kumar, P, Luster, AD, Poluektova, LY, Rao, M, Sanders-Beer, BE, Shultz, LD & Zack, JA 2016, 'Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "meet the Experts" 2015 Workshop Summary', AIDS Research and Human Retroviruses, vol. 32, no. 2, pp. 109-119. https://doi.org/10.1089/aid.2015.0258
Akkina, Ramesh ; Allam, Atef ; Balazs, Alejandro B. ; Blankson, Joel N. ; Burnett, John C. ; Casares, Sofia ; Garcia, J. Victor ; Hasenkrug, Kim J. ; Kashanchi, Fatah ; Kitchen, Scott G. ; Klein, Florian ; Kumar, Priti ; Luster, Andrew D. ; Poluektova, Larisa Y. ; Rao, Mangala ; Sanders-Beer, Brigitte E. ; Shultz, Leonard D. ; Zack, Jerome A. / Improvements and Limitations of Humanized Mouse Models for HIV Research : NIH/NIAID "meet the Experts" 2015 Workshop Summary. In: AIDS Research and Human Retroviruses. 2016 ; Vol. 32, No. 2. pp. 109-119.
@article{94c899b296f34e16931891a1bcf4c505,
title = "Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID {"}meet the Experts{"} 2015 Workshop Summary",
abstract = "The number of humanized mouse models for the human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) and other infectious diseases has expanded rapidly over the past 8 years. Highly immunodeficient mouse strains, such as NOD/SCID/gamma chainnull (NSG, NOG), support better human hematopoietic cell engraftment. Another improvement is the derivation of highly immunodeficient mice, transgenic with human leukocyte antigens (HLAs) and cytokines that supported development of HLA-restricted human T cells and heightened human myeloid cell engraftment. Humanized mice are also used to study the HIV reservoir using new imaging techniques. Despite these advances, there are still limitations in HIV immune responses and deficits in lymphoid structures in these models in addition to xenogeneic graft-versus-host responses. To understand and disseminate the improvements and limitations of humanized mouse models to the scientific community, the NIH sponsored and convened a meeting on April 15, 2015 to discuss the state of knowledge concerning these questions and best practices for selecting a humanized mouse model for a particular scientific investigation. This report summarizes the findings of the NIH meeting.",
author = "Ramesh Akkina and Atef Allam and Balazs, {Alejandro B.} and Blankson, {Joel N.} and Burnett, {John C.} and Sofia Casares and Garcia, {J. Victor} and Hasenkrug, {Kim J.} and Fatah Kashanchi and Kitchen, {Scott G.} and Florian Klein and Priti Kumar and Luster, {Andrew D.} and Poluektova, {Larisa Y.} and Mangala Rao and Sanders-Beer, {Brigitte E.} and Shultz, {Leonard D.} and Zack, {Jerome A.}",
year = "2016",
month = "2",
doi = "10.1089/aid.2015.0258",
language = "English (US)",
volume = "32",
pages = "109--119",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Improvements and Limitations of Humanized Mouse Models for HIV Research

T2 - NIH/NIAID "meet the Experts" 2015 Workshop Summary

AU - Akkina, Ramesh

AU - Allam, Atef

AU - Balazs, Alejandro B.

AU - Blankson, Joel N.

AU - Burnett, John C.

AU - Casares, Sofia

AU - Garcia, J. Victor

AU - Hasenkrug, Kim J.

AU - Kashanchi, Fatah

AU - Kitchen, Scott G.

AU - Klein, Florian

AU - Kumar, Priti

AU - Luster, Andrew D.

AU - Poluektova, Larisa Y.

AU - Rao, Mangala

AU - Sanders-Beer, Brigitte E.

AU - Shultz, Leonard D.

AU - Zack, Jerome A.

PY - 2016/2

Y1 - 2016/2

N2 - The number of humanized mouse models for the human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) and other infectious diseases has expanded rapidly over the past 8 years. Highly immunodeficient mouse strains, such as NOD/SCID/gamma chainnull (NSG, NOG), support better human hematopoietic cell engraftment. Another improvement is the derivation of highly immunodeficient mice, transgenic with human leukocyte antigens (HLAs) and cytokines that supported development of HLA-restricted human T cells and heightened human myeloid cell engraftment. Humanized mice are also used to study the HIV reservoir using new imaging techniques. Despite these advances, there are still limitations in HIV immune responses and deficits in lymphoid structures in these models in addition to xenogeneic graft-versus-host responses. To understand and disseminate the improvements and limitations of humanized mouse models to the scientific community, the NIH sponsored and convened a meeting on April 15, 2015 to discuss the state of knowledge concerning these questions and best practices for selecting a humanized mouse model for a particular scientific investigation. This report summarizes the findings of the NIH meeting.

AB - The number of humanized mouse models for the human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) and other infectious diseases has expanded rapidly over the past 8 years. Highly immunodeficient mouse strains, such as NOD/SCID/gamma chainnull (NSG, NOG), support better human hematopoietic cell engraftment. Another improvement is the derivation of highly immunodeficient mice, transgenic with human leukocyte antigens (HLAs) and cytokines that supported development of HLA-restricted human T cells and heightened human myeloid cell engraftment. Humanized mice are also used to study the HIV reservoir using new imaging techniques. Despite these advances, there are still limitations in HIV immune responses and deficits in lymphoid structures in these models in addition to xenogeneic graft-versus-host responses. To understand and disseminate the improvements and limitations of humanized mouse models to the scientific community, the NIH sponsored and convened a meeting on April 15, 2015 to discuss the state of knowledge concerning these questions and best practices for selecting a humanized mouse model for a particular scientific investigation. This report summarizes the findings of the NIH meeting.

UR - http://www.scopus.com/inward/record.url?scp=84958978795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958978795&partnerID=8YFLogxK

U2 - 10.1089/aid.2015.0258

DO - 10.1089/aid.2015.0258

M3 - Article

C2 - 26670361

AN - SCOPUS:84958978795

VL - 32

SP - 109

EP - 119

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 2

ER -